Results 151 to 160 of about 1,483,959 (183)
Some of the next articles are maybe not open access.
Fully automated and super-rapid system for the detection of JAK2V617F mutation
Leukemia Research, 2008JAK2V617F is a common mutation in chronic myeloproliferative diseases (CMPDs). We have developed a system utilizing JAK2V617F-specific guanine quenching probe (QP-system) to detect JAK2V617F. With QP-system, results can be obtained from 100 microl of blood within 90 min.
Ruriko, Tanaka +16 more
openaire +2 more sources
Possibility of transformation of primary myelofibrosis to ALL without JAK2V617F mutation
Medical Oncology, 2013In this letter, we wish to point out the possibility of transformation of myelofibrosis in acute lymphocytic leukemia without the presence of JAK2V617F mutation. Myeloproliferative neoplasms (MPN) are hematologic malignant diseases characterized by a clonal proliferation of one or several lineages [1].
Vladimir, Jurisic +3 more
openaire +2 more sources
Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN
Journal of Cancer Research and Clinical Oncology, 2017Myeloproliferative neoplasms (MPN) are clonal disorders of hematopoietic stem- and progenitor cells. Mutation of Janus-Kinase 2 (JAK2) is the most frequent genetic event detected in Philadelphia-negative MPN. In advanced phases, the clinical hallmark of the disease is a striking inflammatory syndrome.
Tina M, Schnöder +10 more
openaire +2 more sources
JAK2V617F mutation in patients with β-thalassemia disease: prevalence and clinical characteristics
Annals of Hematology, 2021N. Teawtrakul +3 more
semanticscholar +1 more source
Leukocytosis, JAK2V617F mutation, and hemostasis in myeloproliferative disorders.
Pathophysiology of haemostasis and thrombosis, 2009Thrombosis is a leading cause of morbidity and mortality in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Several mechanisms have been proposed to cause or to contribute to the acquired thrombophilic state of these patients, including platelet and red blood cell abnormalities.
Marina, Marchetti, Anna, Falanga
openaire +1 more source
[Progress of study on JAK2V617F mutation in myeloproliferative neoplasm].
Zhongguo shi yan xue ye xue za zhi, 2012Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell diseases characterized by proliferation of one or more myeloid cell lineages in the bone marrow and increased mature and immature cells in peripheral blood. As the most important discovery in recent studies of MPN, JAk2V617F mutation is considered to closely relate with the ...
Yi-Xin, Chen +3 more
openaire +1 more source
JAK2V617F mutation detection in myeloproliferative disorders (MPD)
2006Recently, a recurrent somatic activating mutation in the janus kinase 2 (JAK2) trosine kinase has been identified in the myeloproliferative disorders (MPDs) polycythemia vera (PV 97%), essential thrombocthemia (ET, 57%) and idiopathic myelofibrosis (MF, 50%).
Bakkus, Marleen +3 more
openaire +1 more source
Quantification of JAK2V617F mutation by next‐generation sequencing technology
American Journal of Hematology, 2013Emna, Abdelhamid +12 more
openaire +2 more sources

